Research Digest

Have a glance at the digested research essence of the latest publications, keeping you up-to-date!

Resources » Learning Center » Research Digest

Categories:

All Gene Oligo Pool Peptide Protein Antibody

Applications:

All Synthetic Biology Genome Editing Protein Engineering Next-Generation Sequencing Cancer Immunotherapy Medical Application Vaccine Development Protein Expression Antibody Production Antibody Development Antibody Discovery

Type:

Application Notes White Papers Research Digest

47 Results

Enhancing Cancer Immunotherapy with Fc-IL-4 and Peptide Activation Services | GenScript

Dec 02, 2024

A New Mode of T cell Suppression by LAG-3 Immune Checkpoint

Oct 24, 2024

Discovering Nanobody-Based Tools to Modulate Protein-Protein Interactions (PPIs)

Oct 09, 2024

Engineering Extracellular Vesicles for Targeted Ovarian Cancer Therapy | GenScript

Explore the latest advancements in ovarian cancer treatment with engineered extracellular vesicles(EVs). Understand how GenScript's innovative approaches enhance targeted drug delivery, offering new hope in overcoming therapeutic challenges like drug resi

Aug 20, 2024

New Opportunities with a Neoantigen-Based Strategy in Rare Liver Cancer | GenScript

New Opportunities with a Neoantigen-Based Strategy in Rare Liver Cancer

Jul 29, 2024

Unveiling the Crucial Roles of Non-Coding Regulatory Elements via Genome-wide Cas9 Screening

Delve into the world of non-coding regulatory elements (NCREs) with this groundbreaking study that utilizes a novel dual-CRISPR system to systematically investigate their functions. Discover how these enigmatic elements influence cell growth and cardiomyo

Jun 25, 2024

CAR-NKT Cells Take Center Stage, Expediting Immunotherapies to More Patients

Jun 20, 2024

Synthetic Lethality Drugs for Cancer: WRN Helicase Inhibitors Show Promise in Early Studies | GenScript

Researchers are developing a new type of cancer treatment that targets a vulnerability in tumor cells called "synthetic lethality." This article explores a specific drug candidate, VVD-133214, which inhibits WRN helicase

May 30, 2024